Thursday July 27, 2017 07:30
Food and Healthcare Press Releases
Pan Rajdhevee Group, Thailand's leading cosmeceutical brand, pushed forth in continuously developing skincare innovations and introduced "Pan Acne Formula Three Lotion," the ultimate acne solution without relying on any medicine. The solution targets
INSECT SHIELD was developed in USA since 1996 at a request by US Military to terminate Lyme Disease brought by Ticks. As a result of 7 years testing and experiments, now US Army and Marine adopts INSECT SHIELD technology to their uniforms. INSECT SHIELD
DAWNING study modified to allow patients the opportunity to receive dolutegravir-based regimens ViiV Healthcare, the global specialist HIV company, majority owned by GSK, with Pfizer Inc. and Shionogi Limited as shareholders, today announced positive
Seegene Inc. (096530.KQ), the world's leading developer of multiplex molecular diagnostics technologies and assays, is to present its unique Seegene Random Access System (the "System") at the 69th AACC Annual Clinical Lab Expo in San Diego, CA, from July
- Celliant-engineered products clinically proven to promote increased localized blood flow - FDA determination to usher in new era of performance fabrics, responsive textiles Hologenix, LLC, maker of Celliant , the world's most advanced, clinically
Multiple Detection Modes and Intuitive Software Help to Simplify and Accelerate Disease Research and Drug Discovery PerkinElmer, Inc. , a global leader committed to innovating for a healthier world, announced on July 24 (US-time) the launch of its new
- If approved, avelumab could be the first immunotherapy treatment indicated for this rare and aggressive skin cancer in the EU - Decision by the EC is expected in the third quarter of 2017 Merck and Pfizer Inc. (NYSE: PFE) today announced that the
- Behind the development of cenegermin are decades of Italian research, stemming from the studies of Rita Levi Montalcini, winner of the Nobel Prize in Medicine for the discovery of the nerve growth factor (NGF). - In 2015, the product was designated as
Cigna launches new phase of operations as the premier provider of health and wellness services to Individuals, Employers and Government entities across the Middle East Cigna Corporation (NYSE: CI), a global health services company, today announced the
- The disease modifying property of GRAZAX(R) (SQ(R) grass SLIT-tablet) resulted in long-term effect on allergic rhinoconjunctivitis (ARC) and prevented asthma symptoms, even two years after end of treatment in children with grass pollen ARC and no
- The company is committed to driving innovation through evolving the product portfolio and investing in potential breakthrough research Merck, a leading science and technology company, today announced its commitment to award EUR1.25 million to research
A simulation study published in BMC Public Health by researchers of the Tyrolean Health and Life Sciences University UMIT, the Oncotyrol center, the Medical University of Innsbruck and the University of Toronto highlights optimized use of prostate cancer
SIRFLOX and FOXFIRE Global findings suggest that adding liver-directed Selective Internal Radiation Therapy (SIRT) to standard first-line chemotherapy may improve overall survival in metastatic colorectal cancer (mCRC) patients with right-sided primary
Novo Nordisk announced today that data from 35 abstracts will be presented at the upcoming International Society on Thrombosis and Haemostasis (ISTH) congress from 8-13 July, in Germany. This data will be featured across posters, abstracts and oral
Singapore and regional healthcare leaders will gather at HIMSS AsiaPac17 from 11 – 14 September at the Marina Bay Sands. Themed Team-Based Care: Unifying Patients and Providers , Guest of Honour Senior Minister of State Chee Hong Tat, Ministry of
- The 8-year follow-up results of a randomized phase 3 multicenter trial in adult patients with hematologic malignancies clearly showed more favorable results in the Grafalon(R) group - Severe GvHD-free and relapse-free survival was 34% in the
Wuttisak Group's direction is to indicating to be a beauty and wellness Asia's leader, expanding by franchise system and there are now morethan 50 prospect franchise units. Wuttisak Group makes the business clearly defined and bring out the strength of
อันฟอร์ส เรย์เซฟ (Unfors RaySafe) ผู้นำระดับโลกด้านโซลูชั่นการรับประกันคุณภาพเอกซเรย์ ประกาศเปิดตัวผลิตภัณฑ์ RaySafe Pro-Slit Phantom และ RaySafe Pro-Stand รูปภาพ - http://mma.prnewswire.com/media/525133/Fluke_Biomedical_Raysafe_Pro_Slit.jpg RaySafe
Unfors RaySafe, the global leader of X-ray quality assurance solutions introduces the RaySafe Pro-Slit Phantom and the RaySafe Pro-Stand. Photo - http://mma.prnewswire.com/media/525133/Fluke_Biomedical_Raysafe_Pro_Slit.jpg The RaySafe Pro-Slit Phantom
QIAGEN (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced its expansion in Thailand and opened an office in Bangkok to enhance relationships with life science researchers and healthcare providers in the growing market. QIAGEN also announced
Swiss technology company Berlinger Special AG has developed a totally new generation of the security bottles which it supplies for anti-doping testing worldwide over the past few months. The new "BEREG-KIT Geneva" security bottles are currently being
LEO Pharma today announced that the first patients have been dosed in a phase 3 clinical study of tralokinumab. Tralokinumab is an investigational human monoclonal antibody that specifically targets the cytokine IL-13[1], which plays an important role in
- Patent covers successful integration of an external DNA sequence into the chromosome of eukaryotic cells using CRISPR - Similar patents pending in other countries; anticipate favorable outcomes , a leading science and technology company, today
- Austria-based Croma-Pharma forms Joint Venture with Sihuan Pharmaceutical to market premium Intradermal-Filler in China, Hong Kong and Macao The registration of Princess(R) VOLUME and the signed Joint Venture open the fastest growing market for